More New EU Drug Approvals Bring Total For Year To 14
Seven new drugs were approved in the EU in the March-April period this year: TiGenix/Takeda's Alofisel, BioCryst's Alpivab, Chiesi's Lamzede, AstraZeneca's Lokelma, Pfizer's Mylotarg, GSK's Shingrix and MSD's Steglatro.
You may also be interested in...
The drug maker is in the midst of launching several new drugs, including the Shingrix vaccine, the triple COPD therapy Trelegy and the HIV regimen Juluca, hoping new drugs will drive growth as Advair sunsets.
TiGenix says its treatment for complex perianal fistulae in Crohn’s disease is the first allogeneic stem cell therapy to be approved under Europe’s centralized marketing authorization pathway.